Moreover, transthyretin (TTR) amyloidosis, an autosomal disorder caused by TTR gene mutations, has seen promising results in therapy using CRISPR-based gene editing with NTLA-2001 [16]. The gene discussed is TTR; the disease is amyloidosis.